ConductScience.org, home

Paper17511683

Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.

Fisher RA and 11 others. Am J Transplant, 2007. Cited by 211 papers, by iCite.

Cite this record

ConductScience Library. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Papers, record 17511683. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17511683

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation.
PubMed
Journal
Am J Transplant
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
211
iCite
Relative citation ratio, by iCite
5.55
iCite
Revised in PubMed
2025-05-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fisher RAR A
2Kulik LML M
3Freise CEC E
4Lok ASA S F
5Shearon THT H
6Brown RS JrR S
7Ghobrial RMR M
8Fair JHJ H
9Olthoff KMK M
10Kam II
11Berg CLC L
12A2ALL Study GroupGroup

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
Liver NeoplasmsMajor topic
Liver TransplantationMajor topic
Living DonorsMajor topic
Postoperative ComplicationsMajor topic
Tissue DonorsMajor topic
Adult
Aged
Cadaver
Cohort Studies
Female
Humans
Male
Middle Aged
Neoplasm Staging
Retrospective Studies
Survival Analysis
Time Factors
Waiting Lists

Source PubMed

Download CSV of topics

Grants10

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 DK062496NIDDK NIH HHSUnited StatesU01DK062496PubMed and NIHNIH RePORTER
U01 DK062536NIDDK NIH HHSUnited StatesU01DK062536PubMed and NIHNIH RePORTER
U01 DK062531NIDDK NIH HHSUnited StatesU01DK062531PubMed and NIHNIH RePORTER
U01 DK062498NIDDK NIH HHSUnited StatesU01DK062498PubMed and NIHNIH RePORTER
U01 DK062444NIDDK NIH HHSUnited StatesU01DK062444PubMed and NIHNIH RePORTER
U01 DK062505NIDDK NIH HHSUnited StatesU01DK062505PubMed and NIHNIH RePORTER
U01 DK062484NIDDK NIH HHSUnited StatesU01DK062484PubMed and NIHNIH RePORTER
U01 DK062494NIDDK NIH HHSUnited StatesU01DK062494PubMed and NIHNIH RePORTER
U01 DK062483NIDDK NIH HHSUnited StatesU01DK062483PubMed and NIHNIH RePORTER
U01 DK062467NIDDK NIH HHSUnited StatesU01DK062467PubMed and NIHNIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00096733Adult-to-Adult Living Donor Liver Transplantation StudyResultsClinicalTrials.gov
NCT01619475Adult-to-Adult Living Donor Transplant Cohort StudyBackgroundClinicalTrials.gov

Download CSV of trials

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
116135918Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium.Ann Surg2005https://conductscience.org/library/papers/16135918PubMed
215004774The role and limitation of living donor liver transplantation for hepatocellular carcinoma.Liver Transpl2004https://conductscience.org/library/papers/15004774PubMed
316315294A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.Liver Transpl2005https://conductscience.org/library/papers/16315294PubMed
412360427Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list.Liver Transpl2002https://conductscience.org/library/papers/12360427PubMed
512200776The quandary over liver transplantation for hepatocellular carcinoma: the greater sin?Liver Transpl2002https://conductscience.org/library/papers/12200776PubMed
615508095Living donor liver transplantation for hepatocellular carcinoma.Gastroenterology2004https://conductscience.org/library/papers/15508095PubMed
79416873United Network for Organ Sharing.Circulation1997https://conductscience.org/library/papers/9416873PubMed
812783395Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome.Liver Transpl2003https://conductscience.org/library/papers/12783395PubMed
911343234Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective.Hepatology2001https://conductscience.org/library/papers/11343234PubMed
1016440361Deaths on the liver transplant waiting list: an analysis of competing risks.Hepatology2006https://conductscience.org/library/papers/16440361PubMed
1111084076American Society of Transplant Surgeons' position paper on adult-to-adult living donor liver transplantation.Liver Transpl2000https://conductscience.org/library/papers/11084076PubMed
1215344951Non-resective ablation therapy for hepatocellular carcinoma: effectiveness measured by intention-to-treat and dropout from liver transplant waiting list.Clin Transplant2004https://conductscience.org/library/papers/15344951PubMed
1415113360Improving liver allocation: MELD and PELD.Am J Transplant2004https://conductscience.org/library/papers/15113360PubMed
1514745321Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma.Ann Surg2004https://conductscience.org/library/papers/14745321PubMed
168594428Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.N Engl J Med1996https://conductscience.org/library/papers/8594428PubMed
1716489583Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma.Liver Transpl2006https://conductscience.org/library/papers/16489583PubMed
1815508093Liver transplantation for hepatocellular carcinoma.Gastroenterology2004https://conductscience.org/library/papers/15508093PubMed
1915319716Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan.Ann Surg2004https://conductscience.org/library/papers/15319716PubMed

Download CSV of references

Cited by100

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.

PMIDTitleJournalYearIn PapersSource
42122246Recurrence of Colorectal Cancer After Liver Transplant for Isolated Colorectal Liver Metastases: A Narrative Review.Cancers (Basel)2026https://conductscience.org/library/papers/42122246PubMed
40866831A serum TNFR2-based model effectively predicates preoperative microvascular invasion and stratifies the tumor recurrence risk in hepatocellular carcinoma.BMC Gastroenterol2025https://conductscience.org/library/papers/40866831PubMed
40806987Liver Transplantation for Cancer-Current Challenges and Emerging Solutions.J Clin Med2025https://conductscience.org/library/papers/40806987PubMed
40636141Liver transplantation for malignant liver tumors.ILIVER2022https://conductscience.org/library/papers/40636141PubMed
40364079Living Donor Liver Transplantation Versus Deceased Donor Liver Transplantation for Hepatocellular Carcinoma and HCV Patients: An Initial Umbrella Review.J Clin Med2025https://conductscience.org/library/papers/40364079PubMed
40361345Development and Validation of a Pre-Transplant Risk Score (LT-MVI Score) to Predict Microvascular Invasion in Hepatocellular Carcinoma Candidates for Liver Transplantation.Cancers (Basel)2025https://conductscience.org/library/papers/40361345PubMed
40206277Hepatocellular Carcinoma and the Role of Liver Transplantation: An Update and Review.J Clin Transl Hepatol2025https://conductscience.org/library/papers/40206277PubMed
39376229
Beyond graft function impairment after liver transplantation: the prolonged cold ischemia time impact on recurrence of hepatocellular carcinoma after liver transplantation-a single-center retrospective study.
PeerJ2024https://conductscience.org/library/papers/39376229PubMed
39281373Outcomes of liver transplantation for hepatocelluler carcinoma from living donor versus deceased donor within University of Southern California San Francisco criteria: a report from Turkey.Front Oncol2024https://conductscience.org/library/papers/39281373PubMed
39183736Living Donor Liver Transplantation for Hepatocellular Carcinoma.J Clin Exp Hepatol2024https://conductscience.org/library/papers/39183736PubMed
39037684Survival benefit of living donor liver transplant for patients with hepatocellular carcinoma.Updates Surg2025https://conductscience.org/library/papers/39037684PubMed
38704462Current role and perspectives of living donor liver transplantation for hepatocellular carcinoma: systematic review of the past 20 years.Updates Surg2025https://conductscience.org/library/papers/38704462PubMed
38439530No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Living Donor Liver Transplantation.Ann Transplant2024https://conductscience.org/library/papers/38439530PubMed
38304238Transplant oncology - Current indications and strategies to advance the field.JHEP Rep2024https://conductscience.org/library/papers/38304238PubMed
37909200
Evaluation of Overall Survival and Disease-Free Survival in Patients Receiving Liver Transplantation for Hepatocellular Carcinoma and Comparison of Living Versus Deceased Donor Liver Transplants: Results of 15 Years of Experience.
Eurasian J Med2023https://conductscience.org/library/papers/37909200PubMed
37512101Updates and Expert Opinions on Liver Transplantation for Gastrointestinal Malignancies.Medicina (Kaunas)2023https://conductscience.org/library/papers/37512101PubMed
37047199Association between Hepatocellular Carcinoma Recurrence and Graft Size in Living Donor Liver Transplantation: A Systematic Review.Int J Mol Sci2023https://conductscience.org/library/papers/37047199PubMed
36672457Surgical Strategies for Recurrent Hepatocellular Carcinoma after Resection: A Review of Current Evidence.Cancers (Basel)2023https://conductscience.org/library/papers/36672457PubMed
36564609Can living donor liver transplantation provide similar outcomes to deceased-donor liver transplantation for hepatocellular carcinoma? A systematic review and meta-analysis.Hepatol Int2023https://conductscience.org/library/papers/36564609PubMed
35406589Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT).Cancers (Basel)2022https://conductscience.org/library/papers/35406589PubMed

See all 100 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17511683

GET https://conductscience.org/api/papers/v1/17511683/cited_by?page=2